Identification of Metabolic Dysregulation and Biomarkers for Clear Cell Renal Cell Carcinoma
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Poplawski P, Tohge T, Boguslawska J, Rybicka B, Tanski Z, Trevino V
. Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients. Biochim Biophys Acta Mol Basis Dis. 2016; 1863(3):744-752.
DOI: 10.1016/j.bbadis.2016.12.011.
View
2.
Li Y, Lih T, Dhanasekaran S, Mannan R, Chen L, Cieslik M
. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell. 2022; 41(1):139-163.e17.
PMC: 9839644.
DOI: 10.1016/j.ccell.2022.12.001.
View
3.
Linehan W, Ricketts C
. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019; 16(9):539-552.
DOI: 10.1038/s41585-019-0211-5.
View
4.
Wettersten H, Abu Aboud O, Lara Jr P, Weiss R
. Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol. 2017; 13(7):410-419.
DOI: 10.1038/nrneph.2017.59.
View
5.
Hakimi A, Reznik E, Lee C, Creighton C, Brannon A, Luna A
. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer Cell. 2016; 29(1):104-116.
PMC: 4809063.
DOI: 10.1016/j.ccell.2015.12.004.
View